XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Net Unrealized Gains (losses) on Investments [Member]
Foreign Currency Translation [Member]
Nonredeemable Noncontrolling Interests [Member]
Balance at Dec. 31, 2020 $ 68,328 $ 10 $ 0 $ 69,295 $ 1,336 $ (5,150) $ 2,837
Balance (in shares) at Dec. 31, 2020   946          
Net earnings attributable to UnitedHealth Group common shareholders 4,862     4,862      
Net earnings attributable to nonredeemable noncontrolling interest             80
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 4,942            
Other comprehensive loss (1,012)       (595) (417)  
Issuances of common stock, and related tax effects (in shares)   3          
Issuances of common stock, and related tax effects 256 $ 0 256        
Share-based compensation 242   242        
Common share repurchases (in shares)   (5)          
Common share repurchases (1,650) $ 0 0 (1,650)      
Cash dividends paid on common shares ($1.45 per share and $1.25 per share for the three months ended March 31, 2022, and 2021, respectively) (1,181)     (1,181)      
Redeemable noncontrolling interests fair value and other adjustments (604)   (498) (106)      
Acquisition and other adjustments of nonredeemable noncontrolling interests 66           66
Distribution to nonredeemable noncontrolling interests (74)           (74)
Balance at Mar. 31, 2021 69,313 $ 10 0 71,220 741 (5,567) 2,909
Balance (in shares) at Mar. 31, 2021   944          
Balance at Dec. 31, 2021 $ 75,045 $ 10 0 77,134 423 (5,807) 3,285
Balance (in shares) at Dec. 31, 2021 941 941          
Net earnings attributable to UnitedHealth Group common shareholders $ 5,027     5,027      
Net earnings attributable to nonredeemable noncontrolling interest             88
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 5,115            
Other comprehensive loss (642)       (1,560) 918  
Issuances of common stock, and related tax effects (in shares)   3          
Issuances of common stock, and related tax effects 333 $ 0 333        
Share-based compensation 282   282        
Common share repurchases (in shares)   (5)          
Common share repurchases (2,500) $ 0 (484) (2,016)      
Cash dividends paid on common shares ($1.45 per share and $1.25 per share for the three months ended March 31, 2022, and 2021, respectively) (1,363)     (1,363)      
Redeemable noncontrolling interests fair value and other adjustments (131)   (131)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 91           91
Distribution to nonredeemable noncontrolling interests (102)           (102)
Balance at Mar. 31, 2022 $ 76,128 $ 10 $ 0 $ 78,782 $ (1,137) $ (4,889) $ 3,362
Balance (in shares) at Mar. 31, 2022 939 939